Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance-Reference-Cited by-同舟云学术

Targeting NAD+ Biosynthesis Overcomes Panobinostat and Bortezomib-Induced Malignant Glioma Resistance

Published:2020-04-01 Issue:7 Volume:18 Page:1004-1017
ISSN:1541-7786
Container-title:Molecular Cancer Research
language:en
Short-container-title:Mol Cancer Res

Author:

Jane Esther P.,Premkumar Daniel R.,Thambireddy Swetha,Golbourn Brian,Agnihotri Sameer,Bertrand Kelsey C.,Mack Stephen C.,Myers Max I.,Chattopadhyay Ansuman,Taylor D. Lansing^ORCID,Schurdak Mark E.,Stern Andrew M.,Pollack Ian F.^ORCID

Funder

Translational Brain Tumor Research Fund

Children's Hospital of Pittsburgh Foundation

University of Pittsburgh Cancer Institute

NIHNCINCI

UPCI

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology,Molecular Biology

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small molecules targeting HDAC6 for cancer treatment: Current progress and novel strategies;Biomedicine & Pharmacotherapy;2024-09

2. Multi-label transcriptional classification of colorectal cancer reflects tumor cell population heterogeneity;Genome Medicine;2023-05-15

3. Targeting mitochondrial energetics reverses panobinostat‐ and marizomib‐induced resistance in pediatric and adult high‐grade gliomas;Molecular Oncology;2023-05-12

4. Dual Nicotinamide Phosphoribosyltransferase (NAMPT) and Indoleamine 2,3-Dioxygenase 1 (IDO1) Inhibitors for the Treatment of Drug-Resistant Nonsmall-Cell Lung Cancer;Journal of Medicinal Chemistry;2023-01-03

5. Brain cancer stem cells: resilience through adaptive plasticity and hierarchical heterogeneity;Nature Reviews Cancer;2022-06-16